The concern associated with the commercial use of ASNases is its high glutaminase activity, which can cause liver dysfunction, pancreatitis, leucopenia, neurological seizures, and coagulation abnormalities that lead to intracranial thrombosis13,14,46. This evidence concerns the gene GLS and pancreatitis.